ConductScience.org, home

Paper1900254

Recombinant human alpha-interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomized controlled trial from France.

Marcellin P and 9 others. Hepatology, 1991. Cited by 352 papers, by iCite.

Cite this record

ConductScience Library. Recombinant human alpha-interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomized controlled trial from France. Papers, record 1900254. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1900254

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Recombinant human alpha-interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomized controlled trial from France.
PubMed
Journal
Hepatology
PubMed
Year
1991
PubMed
Publication types
Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial
PubMed
Citations, by iCite
352
iCite
Relative citation ratio, by iCite
13.5
iCite
Revised in PubMed
2011-11-17
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Marcellin PP
2Boyer NN
3Giostra EE
4Degott CC
5Courouce AMA M
6Degos FF
7Coppere HH
8Cales PP
9Couzigou PP
10Benhamou JPJ P

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hepatitis CMajor topic
Interferon Type IMajor topic
Recombinant ProteinsMajor topic
Adult
Alanine Transaminase
Female
France
Humans
Male

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in1900256Therapy of chronic hepatitis C with alpha-interferon: the answer? Or more questions?https://conductscience.org/library/papers/1900256

Source PubMed

Download CSV of comments and corrections

Cited by48

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 352 citations.

PMIDTitleJournalYearIn PapersSource
31213010Humanized Mouse Models for the Study of Hepatitis C and Host Interactions.Cells2019https://conductscience.org/library/papers/31213010PubMed
23745021Sofosbuvir and ABT-450: terminator of hepatitis C virus?World J Gastroenterol2013https://conductscience.org/library/papers/23745021PubMed
18370481Comparison among Different Types, Dosages and Duration of Interferon Therapy in Chronic Hepatitis C.Clin Drug Investig1998https://conductscience.org/library/papers/18370481PubMed
16501853Antiviral therapy for chronic hepatitis C: past, present, and future.J Gastroenterol2006https://conductscience.org/library/papers/16501853PubMed
15546094Infrequent reinfection after successful treatment for hepatitis C virus infection in injection drug users.Clin Infect Dis2004https://conductscience.org/library/papers/15546094PubMed
12498286Normalization of markedly elevated alpha-fetoprotein in a virologic nonresponder with HCV-related cirrhosis.Dig Dis Sci2002https://conductscience.org/library/papers/12498286PubMed
12076394Interferon for interferon naive patients with chronic hepatitis C.Cochrane Database Syst Rev2002https://conductscience.org/library/papers/12076394PubMed
11678904IgG1 anti-P2 as a marker of response to interferon in patients with chronic hepatitis C.Clin Exp Immunol2001https://conductscience.org/library/papers/11678904PubMed
11177692Pegylated interferons: what role will they play in the treatment of chronic hepatitis C?Curr Gastroenterol Rep2001https://conductscience.org/library/papers/11177692PubMed
10829940Hepatitis B, C & D viral markers in multitransfused thalassemic children: long-term complications and present management.Indian J Pediatr1995https://conductscience.org/library/papers/10829940PubMed
10369715Response to interferon alpha treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virus.Gut1999https://conductscience.org/library/papers/10369715PubMed
10363572Lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C: a pilot study.Jpn J Cancer Res1999https://conductscience.org/library/papers/10363572PubMed
9733898Optimal induction of hepatitis C virus envelope-specific immunity by bicistronic plasmid DNA inoculation with the granulocyte-macrophage colony-stimulating factor gene.J Virol1998https://conductscience.org/library/papers/9733898PubMed
9690395Value of liver biopsy prior to interferon therapy for chronic viral hepatitis.Dig Dis Sci1998https://conductscience.org/library/papers/9690395PubMed
9342559Hepatitis C virus infection in the elderly. Epidemiology, prophylaxis and optimal treatment.Drugs Aging1997https://conductscience.org/library/papers/9342559PubMed
9246043Long-term efficacy of interferon-alpha and ursodeoxycholic acid in treatment of chronic type C hepatitis.Dig Dis Sci1997https://conductscience.org/library/papers/9246043PubMed
9173207[Therapy of hepatitis C].Med Klin (Munich)1997https://conductscience.org/library/papers/9173207PubMed
9058296Efficacy of combination therapy of interferon-alpha with ursodeoxycholic acid in chronic hepatitis C: a randomized controlled clinical trial.J Gastroenterol1997https://conductscience.org/library/papers/9058296PubMed
9011483Two years versus six months of interferon therapy for chronic hepatitis C.Dig Dis Sci1996https://conductscience.org/library/papers/9011483PubMed
9011468Predictors of response to interferon therapy.Dig Dis Sci1996https://conductscience.org/library/papers/9011468PubMed

See all 48 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1900254

GET https://conductscience.org/api/papers/v1/1900254/cited_by?page=2